Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms

We used data from 852 consecutive subjects with myelodysplastic neoplasms (MDS) diagnosed according to the 2016 (revised 4th) World Health Organization (WHO) criteria to evaluate the 2022 (5th) edition WHO classification of MDS. 30 subjects previously classified as MDS with an NPM1 mutation were re-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yudi, Wu, Junying, Qin, Tiejun, Xu, Zefeng, Qu, Shiqiang, Pan, Lijuan, Li, Bing, Wang, Huijun, Zhang, Peihong, Yan, Xin, Gong, Jingye, Gao, Qingyan, Gale, Robert Peter, Xiao, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712101/
https://www.ncbi.nlm.nih.gov/pubmed/36224330
http://dx.doi.org/10.1038/s41375-022-01718-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712101/
https://www.ncbi.nlm.nih.gov/pubmed/36224330
http://dx.doi.org/10.1038/s41375-022-01718-7

Ejemplares similares